Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Neoplasms 5Lung Neoplasms 4Glioblastoma 3Urinary Bladder Neoplasms 2Glioma 2Brain Neoplasms 2Astrocytoma 2Uterine Cervical Neoplasms 1Tuberculosis, Pulmonary 1Thyroid Nodule 1Stomach Neoplasms 1Solitary Pulmonary Nodule 1Pulmonary Fibrosis 1Pulmonary Embolism 1Pulmonary Disease, Chronic Obstructive 1Pulmonary Arterial Hypertension 1Pleural Neoplasms 1Pancreatic Neoplasms 1Non-Muscle Invasive Bladder Neoplasms 1Multiple Pulmonary Nodules 1Mesothelioma 1Lung Injury 1Lung Diseases, Interstitial 1Lung Diseases 1Lung Abscess 1Esophageal Neoplasms 1Emphysema 1Disease 1Cystic Fibrosis 1Colorectal Neoplasms 1

Interventions

Sorafenib 79pembrolizumab 37Bevacizumab 36Nivolumab 33lenvatinib 30atezolizumab 24durvalumab 17Oxaliplatin 12Ipilimumab 12regorafenib 9Capecitabine 9tremelimumab 8Injections 8Doxorubicin 8tislelizumab 7sintilimab 7Fluorouracil 7cabozantinib 6budigalimab 6brivanib 6Ramucirumab 6toripalimab 5Gemcitabine 5Everolimus 5Cyclophosphamide 5ADI PEG20 5fludarabine 4Sunitinib 4Leucovorin 4E-7386 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Hepatocellular × Drug Delivery Systems × Clear all
NCT01078415 2016-11-08

Pilot Study of Irreversible Electroporation (IRE) to Treat Early-Stage Primary Liver Cancer (HCC)

Angiodynamics, Inc.

Phase NA Completed
26 enrolled
Gastrointestinal

Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡